FDA Approves Penpulimab-kcqx for Non-keratinizing Nasopharyngeal Carcinoma By Ogkologos - May 23, 2025 566 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study AK105-304 and Study AK105-202 Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple Myeloma March 30, 2022 Baby Boy Can’t Stop Smiling After Surgery Allows Him To See... September 18, 2019 FDA Approves Safety Labelling Changes Regarding DPD Deficiency for Fluorouracil Injection... April 19, 2024 Listening to Patient Narratives June 9, 2020 Load more HOT NEWS Holidays and Hope When a Loved One Has Advanced Cancer Celebrate with Us! Vaccine Rollouts Mark the Light at the End... 5-Yr-Old Has Cutest Celebration With Big Brother After Being Declared Cancer-Free. New breast and lung cancer treatments approved in Scotland
